USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CIVATECH ONCOLOGY, INC.
Address:
104 TW ALEXANDER DR Bldg # 4
RESEARCH TRIANGLE PARK, NC 27709-
Phone:
N/A
URL:
N/A
EIN:
204705260
DUNS:
801431862
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $199,266.00 1
SBIR Phase II $998,964.00 1

Award List:

Not Available

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$199,266.00
Agency:
HHS
Principal Investigator:
Seth Hoedl – (919) 314-5515
Abstract:
The use of LDR brachytherapy after sub-lobar lung resection is the focus of a phase III NCI sponsored trial. Early clinical results from independent studies suggest that brachytherapy enables a singificant reduction in local recurrence rates versus surgery alone. Civatech Oncology and Allegheny… More

IGF::OT::IGF OTHER FUNCTIONS DEVELOPMENT OF A UNI-DIRECTIONAL BRACHYTHERAPY DEVICE FOR THE TREATMENT OF NON-SMALL-CELL LUNG CANCER

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$998,964.00
Agency:
HHS
Principal Investigator:
Kristy Perez – 919-314-5515
Abstract:
According to the American Cancer Society 220,000 men and women in the U.S. develop lung and bronchial cancer every year and 147,000 die of the disease. Of lung cancer patients, 85% present with non-small-cell lung cancer and 16.7% of these will present with localized disease. Note that lung cancer… More